Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Rapid Dose Therapeutics Corp ( (TSE:DOSE) ) has provided an announcement.
Rapid Dose Therapeutics Corp announced an update on its debt settlement plan involving the issuance of up to 1,600,000 common shares to creditors in exchange for canceling $400,000 of outstanding accounts payable. Additionally, the company has decided not to proceed with a previously proposed private placement of up to $6,000,000. This move reflects a shift in the company’s financial strategy, potentially impacting its liquidity and market positioning.
More about Rapid Dose Therapeutics Corp
Rapid Dose Therapeutics Corp is a Canadian biotechnology company focused on innovating drug delivery systems. Its flagship product, QuickStrip™, is a thin, orally dissolvable film that can be infused with a wide range of active ingredients, including nutraceuticals, pharmaceuticals, and vaccines, allowing for rapid absorption into the bloodstream.
YTD Price Performance: -8.89%
Average Trading Volume: 45,147
Technical Sentiment Consensus Rating: Hold
Current Market Cap: C$25.55M
For detailed information about DOSE stock, go to TipRanks’ Stock Analysis page.
